Involvement of gap junctions in tumor suppression: Analysis of genetically-manipulated mice

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 477, Issue 1-2, 2001, Pages 191-196

  Omori, Yasufumi ^a   Zaidan Dagli, Maria Lúcia ^a   Yamakage, Kohji ^a   Yamasaki, Hiroshi ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Carcinogenesis; Connexin; Dominant negative mutant; Gap junction; Knockout mouse; Transgenic mouse

Indexed keywords

ALBUMIN; BROXURIDINE; CONNEXIN 32; CONNEXIN 43; DIETHYLNITROSAMINE; GAP JUNCTION PROTEIN; MUTANT PROTEIN;

ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL COMMUNICATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; DOWN REGULATION; GAP JUNCTION; GENE ACTIVITY; GENE DELETION; GENETIC MANIPULATION; LIVER CARCINOGENESIS; LIVER REGENERATION; NONHUMAN; PARTIAL HEPATECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIVISION; CONNEXINS; GAP JUNCTIONS; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER; MICE; MUTATION; PHENOTYPE;

MUS MUSCULUS;

EID: 0035796056     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00120-8     Document Type: Article

References (29)

1. Bruzzone R., White T.W., Paul D.L. Connections with connexins: the molecular basis of direct intercellular signaling. Eur. J. Biochem. 238:1996;1-27.
2. Trosko J.E., Ruch R.J. Cell-cell communication in carcinogenesis. Front. Biosci. 3:1998;d208-d236.
3. Yamasaki H., Naus C.C.G. Role of connexin genes in growth control. Carcinogenesis. 17:1996;1199-1213.
4. Omori Y., Krutovskikh V., Mironov N., Tsuda H., Yamasaki H. Cx32 gene mutation in a chemically induced rat liver tumour. Carcinogenesis. 17:1996;2077-2080.
5. Saito T., Barbin A., Omori Y., Yamasaki H. Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride. Cancer Res. 57:1997;375-377.
6. Mironov N.M., Aguelon A.-M., Potapova G.I., Omori Y., Gorbunov O.V., Klimenkov A.A., Yamasaki H. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res. 54:1994;41-44.
7. Krutovskikh V., Mazzoleni G., Mironov N., Omori Y., Aguelon A.-M., Mesnil M., Berger F., Partensky C., Yamasaki H. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int. J. Cancer. 56:1994;87-94.
8. Krutovskikh V., Yamasaki H. The role of gap junctional intercellular communication (GJIC) disorders in experimental and human carcinogenesis. Histol. Histopathol. 12:1997;761-768.
9. Zhu D., Caveney S., Kidder G.M., Naus C.C.G. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 88:1991;1883-1887.
10. Mesnil M., Krutovskikh V., Piccoli C., Elfgang C., Traub O., Willecke K., Yamasaki H. Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res. 55:1995;629-639.
11. Temme A., Buchmann A., Gabriel H.D., Nelles E., Schwarz M., Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin 32. Curr. Biol. 7:1997;713-716.
12. Moennikes O., Buchmann A., Ott T., Willecke K., Schwarz M. The effect of connexin 32 null mutation on hepatocarcinogenesis in different mouse strains. Carcinogenesis. 20:1999;1379-1382.
13. Reaume A.G., de Sousa P.A., Kulkarni S., Langille B.L., Zhu D., Davies T.C., Juneja S.C., Kidder G.M., Rossant J. Cardiac malformation in neonatal mice lacking connexin 43. Science. 267:1995;1831-1834.
14. Gabriel H.D., Jung D., Butzler C., Temme A., Traub O., Winterhager E., Willecke K. Transplacental uptake of glucose is decreased in embryonic lethal connexin 26-deficient mice. J. Cell Biol. 140:1998;1453-1461.
15. Omori Y., Mesnil M., Yamasaki H. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol. Biol. Cell. 7:1996;907-916.
16. Loewenstein W.R. Junctional intercellular communication: the cell-to-cell membrane channel. Physiol. Rev. 61:1981;829-913.
17. Nelles E., Butzler C., Jung D., Temme A., Gabriel H.D., Dahl U., Traub O., Stumpel F., Jungermann K., Zielasek J., Toyka K.V., Dermietzel R., Willecke K. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin 32-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9565-9570.
18. Temme A., Ott T., Dombrowski F., Willecke K. The extent of synchronous initiation and termination of DNA synthesis in regenerating mouse liver is dependent on connexin 32 expressing gap junctions. J. Hepatol. 32:2000;627-635.
19. Yamakage K., Omori Y., Piccoli C., Yamasaki H. Growth control of 3T3 fibroblast cell lines established from connexin 43-deficient mice. Mol. Carcinog. 23:1998;121-128.
20. Martyn K.D., Kurata W.E., Warn-Cramer B.J., Burt J.M., TenBroek E., Lau A.F. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ. 8:1997;1015-1027.
21. Naus C.C.G., Bechberger J.F., Zhang Y., Venance L., Yamasaki H., Juneja S.C., Kidder G.M., Giaume C. Altered gap junctional communication, intercellular signaling. J. Neurosci. Res. 49:1997;528-540.
22. Yamakage K., Omori Y., Zaidan-Dagli M.L., Cros M.P., Yamasaki H. Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted. J. Invest. Dermatol. 114:2000;289-294.
23. Simon A.M., Goodenough D.A., Li E., Paul D.L. Female infertility in mice lacking connexin 37. Nature. 385:1997;525-529.
24. Simon A.M., Goodenough D.A., Paul D.L. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr. Biol. 8:1998;295-298.
25. Kirchhoff S., Nelles E., Hagendorff A., Kruger O., Traub O., Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin 40-deficient mice. Curr. Biol. 8:1998;299-302.
26. Kumai M., Nishii K., Nakamura K., Takeda N., Suzuki M., Shibata Y. Loss of connexin 45 causes a cushion defect in early cardiogenesis. Development. 127:2000;3501-3512.
27. Kruger O., Plum A., Kim J., Winterhager E., Maxeiner S., Hallas G., Kirchhoff S., Traub O., Lamers W.H., Willecke K. Defective vascular development in connexin 45-deficient mice. Development. 127:2000;4179-4193.
28. Gong X., Li E., Klier G., Huang Q., Wu Y., Lei H., Kumar N.M., Horwitz J., Gilula N.B. Disruption of alpha 3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell. 91:1997;833-843.
29. White T.W., Goodenough D.A., Paul D.L. Targeted ablation of connexin 50 in mice results in microphthalmia and zonular pulverulent cataracts. J. Cell Biol. 143:1998;815-825.